XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net income $ 9,370 $ 17,109
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 33,118 25,291
Amortization of right-of-use assets 2,371 1,848
Amortization of debt issuance costs 161 170
Stock-based compensation 88,763 49,486
Deferred income taxes 5,504 (741)
Change in fair value of other equity security (302) 0
Unrealized foreign exchange loss (gain) 58 (1,277)
Gain on sale of assets held for sale (14,337) 0
Gain on sale of available-for-sale debt security (648) 0
Loss on disposal of property and equipment 150 49
Other 102 0
Changes in operating assets and liabilities:    
Accounts receivable (11,659) 220
Prepaid expenses and other current assets (897) (5,321)
Other assets 1,003 58
Accounts payable 1,923 (3,736)
Accrued expenses and other liabilities 1,425 (6,175)
Operating lease liabilities (1,791) (1,654)
Income tax payable 246 (52)
Deferred revenue 29,508 17,778
Net cash provided by operating activities 144,068 93,053
Cash flows from investing activities    
Acquisition, net of cash acquired (48,468) 0
Proceeds from sale of assets held for sale 37,051 0
Proceeds from sale of available-for-sale debt security 1,507 0
Purchase of property and equipment (24,144) (28,989)
Net cash used in investing activities (34,054) (28,989)
Cash flows from financing activities    
Payment of debt issuance costs (841) 0
Proceeds from issuance of stock under employee stock plans 44,662 1,862
Repayment of capital lease obligations (2) (19)
Repurchase of common stock (37,621) (161,959)
Share repurchase costs (excise tax) (1,264) 0
Shares surrendered for settlement of minimum statutory tax withholding (19,965) (17,216)
Net cash used in financing activities (15,031) (177,332)
Effect of exchange rate changes on cash and cash equivalents 107 26
Net increase (decrease) in cash and cash equivalents 95,090 (113,242)
Cash and cash equivalents, at beginning of the period 142,064 225,719
Cash and cash equivalents, at end of the period 237,154 112,477
Non-cash operating, investing, and financing activities:    
Acquisition-related deferred consideration  12,486 0
Accrued stock repurchase excise tax 0 1,295
Accrued stock repurchase costs 364 754
Issuance of common stock for business acquired 20,048 0
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities 1,198 1,971
Capitalized stock-based compensation 4,253 4,580
Right-of-use assets obtained in exchange of operating lease liabilities (excluding right-of-use assets acquired as part of business acquisition) $ 5,083 $ 682